Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabis and Psychosis: a Critical Overview of the Relationship
Charles Ksir, Carl L. Hart
Current Psychiatry Reports (2016) Vol. 18, Iss. 2
Closed Access | Times Cited: 169

Showing 1-25 of 169 citing articles:

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Marta Di Forti, Diego Quattrone, Tom P. Freeman, et al.
The Lancet Psychiatry (2019) Vol. 6, Iss. 5, pp. 427-436
Open Access | Times Cited: 707
Demographic, physical and mental health assessments in the adolescent brain and cognitive development study: Rationale and description
Deanna M. Barch, Matthew D. Albaugh, Shelli Avenevoli, et al.
Developmental Cognitive Neuroscience (2017) Vol. 32, pp. 55-66
Open Access | Times Cited: 648
Cannabis use and cannabis use disorder
Jason P. Connor, Daniel Stjepanović, Bernard Le Foll, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 300
Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis
Robin M. Murray, Harriet Quigley, Diego Quattrone, et al.
World Psychiatry (2016) Vol. 15, Iss. 3, pp. 195-204
Open Access | Times Cited: 249
Cannabis use and psychosis: a review of reviews
Alkomiet Hasan, Rupert von Keller, Chris M. Friemel, et al.
European Archives of Psychiatry and Clinical Neuroscience (2019) Vol. 270, Iss. 4, pp. 403-412
Closed Access | Times Cited: 199
Cannabis-associated psychosis: Neural substrate and clinical impact
Robin M. Murray, Amir Englund, Anissa Abi‐Dargham, et al.
Neuropharmacology (2017) Vol. 124, pp. 89-104
Closed Access | Times Cited: 177
Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
Zeinab Breijyeh, Buthaina Jubeh, Sabino Aurelio Bufo, et al.
Toxins (2021) Vol. 13, Iss. 2, pp. 117-117
Open Access | Times Cited: 84
Cannabis use in Adolescence and Risk of Psychosis: Are there Factors that Moderate this Relationship? A Systematic Review and Meta-Analysis
Sarah Kanana Kiburi, Keneilwe Molebatsi, Vuyokazi Ntlantsana, et al.
Substance Abuse (2021) Vol. 42, Iss. 4, pp. 527-542
Closed Access | Times Cited: 84
Implementing social justice in the transition from illicit to legal cannabis
Bryon Adinoff, Amanda Reiman
The American Journal of Drug and Alcohol Abuse (2019) Vol. 45, Iss. 6, pp. 673-688
Closed Access | Times Cited: 78
Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis
Tessa Robinson, Muhammad Usman Ali, Bethany Easterbrook, et al.
Psychological Medicine (2022) Vol. 53, Iss. 9, pp. 3858-3868
Open Access | Times Cited: 40
Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?
Jasmine Turna, Beth Patterson, Michael Van Ameringen
Depression and Anxiety (2017) Vol. 34, Iss. 11, pp. 1006-1017
Open Access | Times Cited: 85
Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005–17: the role of differentially changing risk perceptions
Lauren R. Pacek, Andrea H. Weinberger, Jiaqi Zhu, et al.
Addiction (2019) Vol. 115, Iss. 5, pp. 935-943
Open Access | Times Cited: 68
TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids
Kathleen Louis-Gray, Srinivasan Tupal, Louis S. Premkumar
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10016-10016
Open Access | Times Cited: 32
Unhealthy behaviors associated with mental health disorders: a systematic comparative review of diet quality, sedentary behavior, and cannabis and tobacco use
Petter Grahl Johnstad
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 6
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
Marco Colizzi, Mirella Ruggeri, Sagnik Bhattacharyya
Frontiers in Psychology (2020) Vol. 11
Open Access | Times Cited: 49
“Something that actually works”: Cannabis use among young people in the context of street entrenchment
Braedon Ronald Paul, Madison Thulien, Rod Knight, et al.
PLoS ONE (2020) Vol. 15, Iss. 7, pp. e0236243-e0236243
Open Access | Times Cited: 46
Marijuana Legalization and Youth
Kristie Ladegard, Christian Thurstone, Melanie Rylander
PEDIATRICS (2020) Vol. 145, Iss. Supplement_2, pp. S165-S174
Open Access | Times Cited: 45
Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review
Megan S. Farris, Mohammed K. Shakeel, Jean Addington
Social Psychiatry and Psychiatric Epidemiology (2019) Vol. 55, Iss. 5, pp. 527-537
Closed Access | Times Cited: 44
Cannabis Legalization and the Decline of Cannabis Use Disorder (CUD) Treatment Utilization in the US
Jeremy Mennis, Gerald J. Stahler, Michael J. Mason
Current Addiction Reports (2023) Vol. 10, Iss. 1, pp. 38-51
Closed Access | Times Cited: 15
The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors
Kelly A. Sagar, Staci A. Gruber
CNS Drugs (2025)
Closed Access
Does Cannabis Use Contribute to Schizophrenia? A Causation Analysis Based on Epidemiological Evidence
Sepehr Pourebrahim, Tuba Ahmad, Elisabeth Rottmann, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 368-368
Open Access
Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression
Mario Stampanoni Bassi, Luana Gilio, Pierpaolo Maffei, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 42
Guidelines for public health and safety metrics to evaluate the potential harms and benefits of cannabis regulation in Canada
Stephanie Lake, Thomas Kerr, Dan Werb, et al.
Drug and Alcohol Review (2019) Vol. 38, Iss. 6, pp. 606-621
Closed Access | Times Cited: 40
Cannabis and Psychosis Through the Lens of DSM-5
Nathan Pearson, James H. Berry
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 21, pp. 4149-4149
Open Access | Times Cited: 40
Medical Cannabis Use in Glioma Patients Treated at a Comprehensive Cancer Center in Florida
Maija Reblin, Solmaz Sahebjam, Noah C. Peeri, et al.
Journal of Palliative Medicine (2019) Vol. 22, Iss. 10, pp. 1202-1207
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top